%0 Journal Article
%T Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements.
%A Laver TW
%A Wakeling MN
%A Caswell RC
%A Bunce B
%A Yau D
%A Männistö JME
%A Houghton JAL
%A Hopkins JJ
%A Weedon MN
%A Saraff V
%A Kershaw M
%A Honey EM
%A Murphy N
%A Giri D
%A Nath S
%A Tangari Saredo A
%A Banerjee I
%A Hussain K
%A Owens NDL
%A Flanagan SE
%J Eur J Hum Genet
%V 32
%N 7
%D 2024 Jul 11
%M 38605124
%F 5.351
%R 10.1038/s41431-024-01593-z
%X Persistent congenital hyperinsulinism (HI) is a rare genetically heterogeneous condition characterised by dysregulated insulin secretion leading to life-threatening hypoglycaemia. For up to 50% of affected individuals screening of the known HI genes does not identify a disease-causing variant. Large deletions have previously been used to identify novel regulatory regions causing HI. Here, we used genome sequencing to search for novel large (>1 Mb) deletions in 180 probands with HI of unknown cause and replicated our findings in a large cohort of 883 genetically unsolved individuals with HI using off-target copy number variant calling from targeted gene panels. We identified overlapping heterozygous deletions in five individuals (range 3-8 Mb) spanning chromosome 20p11.2. The pancreatic beta-cell transcription factor gene, FOXA2, a known cause of HI was deleted in two of the five individuals. In the remaining three, we found a minimal deleted region of 2.4 Mb adjacent to FOXA2 that encompasses multiple non-coding regulatory elements that are in conformational contact with FOXA2. Our data suggests that the deletions in these three children may cause disease through the dysregulation of FOXA2 expression. These findings provide new insights into the regulation of FOXA2 in the beta-cell and confirm an aetiological role for chromosome 20p11.2 deletions in syndromic HI.